Neuromodulation device Relivion gets FDA clearance to help patients with major depression who don’t benefit from antidepressant medications

By SharpBrains | August 12, 2020

Neu­rolief wins FDA break­through nod for wear­able neu­ro­mod for depres­sion (Mass Device): Neu­rolief announced today that it received FDA break­through device des­ig­na­tion for its Reliv­ion DP sys­tem for treat­ing major depres­sion. Reliv­ion is a wear­able, non-inva­­sive, mul­ti-chan­nel brain neu­ro­mod­u­la­tion device designed as an adjunc­tive treat­ment to phar­ma­ceu­ti­cal man­age­ment of major depres­sive dis­or­der (MDD) in adults…

Read More

Transcranial Direct Current Stimulation (tDCS) as depression treatment: much promise, some DIY risks

By Drs. Kerrie-Anne Ho and Colleen Loo | December 5, 2014 |

Around 350 mil­lion peo­ple world­wide have depres­sion. Anti­de­pres­sant med­ica­tions are often pre­scribed to treat the con­di­tion, along­side talk­ing ther­a­pies and lifestyle changes such as reg­u­lar exer­cise. But a sub­stan­tial pro­por­tion of peo­ple either don’t respond to anti­de­pres­sants, or expe­ri­ence such sig­nif­i­cant side effects that they’d pre­fer not to take them. In search of 

Read More